Intrexon | XON - Trade Debtors

Intrexon reported $13.8M in Trade Debtors for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Trade Debtors Change
Agenus AGEN:US USD 2.74M 6.08M
Amgen AMGN:US USD 5.56B 237M
Anika Therapeutics ANIK:US USD 34.63M 459K
Arrowhead Research ARWR:US USD 39.57M 38.16M
AstraZeneca AZN:LN USD 11.25B 1.19B
Gilead Sciences GILD:US USD 4.78B 423M
GlaxoSmithKline GSK:LN GBP 7.46B 636M
Heron Therapeutics HRTX:US USD 42.19M 1.88M
Immunogen IMGN:US USD 17.98M 13.79M
Intrexon XON:US USD 13.8M 11.35M
Karyopharm Therapeutics KPTI:US USD 47.09M 19.64M
Ligand Pharmaceuticals LGND:US USD 35.04M 30.92M
Macrogenics MGNX:US USD 56.22M 42.38M
Mannkind MNKD:US USD 16.8M 6.69M
Novartis NOVN:VX USD 8.33B 346M
Peregrine Pharmaceuticals PPHM:US USD 25.21M 1.89M
Rigel Pharmaceuticals RIGL:US USD 40.32M 24.8M
Roche Holding ROG:VX 11.92B 841M
Sangamo Biosciences SGMO:US USD 4.47M 574K
Thermo Fisher Scientific TMO:US USD 8.27B 645M
Veracyte VCYT:US USD 44.02M 3.95M
Xencor XNCR:US USD 29M 15.88M
YTE INCY:US USD 644.88M 26.69M
Ziopharm Oncology ZIOP:US USD 4K 2.91M